From business publication BioProcess International comes The BioProcess Insider Expression Platform (BIEP). Editor Dan Stanton takes a look beyond the nuts and bolts of the biomanufacturing industry and speaks to some of the pioneers and thought leaders turning production on its head.
Having raised $82 million in its latest funding round, tech firm Cellares Corporation is looking to advance development of its cell therapy manufacturing platform, the Cell Shuttle.
We spoke with co-founder and CEO Fabian Gerlinghaus about the current limitations in CAR-T production and how...
Ernst & Young’s Adlai Goldberg describes the steps industry must take to advance the advanced therapy space and how it must move to balance the individualized autologous approach with more sustainable allogeneic products.
Vincenza Pironti - Global SME, Steriles, ThermoFisher Scientific - sits down (at a distance) with editor Dan Stanton to discuss aseptic manufacturing in the current climate and how vaccine and biologic makers can ensure a robust, global fill/finish supply both during the COVID pandemic and beyond